- Home
- CISO vs CRIS Comparison
CISO vs CRIS Comparison
Compare CISO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- CRIS
- Stock Information
- Founded
- CISO 2015
- CRIS 2000
- Country
- CISO United States
- CRIS United States
- Employees
- CISO N/A
- CRIS N/A
- Industry
- CISO Computer Software: Prepackaged Software
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISO Technology
- CRIS Health Care
- Exchange
- CISO Nasdaq
- CRIS Nasdaq
- Market Cap
- CISO 12.4M
- CRIS 32.8M
- IPO Year
- CISO N/A
- CRIS 2000
- Fundamental
- Price
- CISO $1.09
- CRIS $2.84
- Analyst Decision
- CISO
- CRIS Strong Buy
- Analyst Count
- CISO 0
- CRIS 3
- Target Price
- CISO N/A
- CRIS $23.00
- AVG Volume (30 Days)
- CISO 401.5K
- CRIS 28.2K
- Earning Date
- CISO 04-15-2025
- CRIS 05-06-2025
- Dividend Yield
- CISO N/A
- CRIS N/A
- EPS Growth
- CISO N/A
- CRIS N/A
- EPS
- CISO N/A
- CRIS N/A
- Revenue
- CISO $54,633,909.00
- CRIS $10,259,000.00
- Revenue This Year
- CISO $78.76
- CRIS N/A
- Revenue Next Year
- CISO N/A
- CRIS N/A
- P/E Ratio
- CISO N/A
- CRIS N/A
- Revenue Growth
- CISO 34.87
- CRIS 0.44
- 52 Week Low
- CISO $0.26
- CRIS $2.57
- 52 Week High
- CISO $3.84
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- CISO 50.35
- CRIS 41.65
- Support Level
- CISO $0.96
- CRIS $2.57
- Resistance Level
- CISO $1.10
- CRIS $3.15
- Average True Range (ATR)
- CISO 0.14
- CRIS 0.17
- MACD
- CISO 0.01
- CRIS -0.02
- Stochastic Oscillator
- CISO 54.15
- CRIS 44.26
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.